Ishii Koji, Murakami Kyoko, Hmwe Su Su, Zhang Bin, Li Jin, Shirakura Masayuki, Morikawa Kenichi, Suzuki Ryosuke, Miyamura Tatsuo, Wakita Takaji, Suzuki Tetsuro
Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Biochem Biophys Res Commun. 2008 Jul 4;371(3):446-50. doi: 10.1016/j.bbrc.2008.04.110. Epub 2008 Apr 28.
A trans-packaging system for hepatitis C virus (HCV) subgenomic replicon RNAs was developed. HCV subgenomic replicon was efficiently encapsidated by the HCV structural proteins that were stably expressed in trans under the control of a mammalian promoter. Infectious HCV-like particles (HCV-LPs), established a single-round infection, were produced and released into culture medium in titers of up to 10(3) focus forming units/ml. Expression of NS2 protein with structural proteins (core, E1, E2, and p7) was shown to be critical for the infectivity of HCV-LPs. Anti-CD81 treatment decreased the number of infected cells, suggesting that HCV-LPs infected cells in a CD81-dependent manner. The packaging cell line should be useful both for the production of single-round infectious HCV-LPs to elucidate the mechanisms of HCV assembly, particle formation and infection to host cells, and for the development of HCV replicon-based vaccines.
我们开发了一种用于丙型肝炎病毒(HCV)亚基因组复制子RNA的转包装系统。HCV亚基因组复制子被HCV结构蛋白有效衣壳化,这些结构蛋白在哺乳动物启动子的控制下在反式中稳定表达。产生了建立单轮感染的传染性HCV样颗粒(HCV-LPs),并以高达10³个焦点形成单位/毫升的滴度释放到培养基中。NS2蛋白与结构蛋白(核心、E1、E2和p7)的表达对HCV-LPs的感染性至关重要。抗CD81处理减少了感染细胞的数量,表明HCV-LPs以CD81依赖性方式感染细胞。该包装细胞系对于生产单轮传染性HCV-LPs以阐明HCV组装、颗粒形成和感染宿主细胞的机制以及基于HCV复制子的疫苗的开发都应是有用的。